Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Targeting the RUNX3–miR-186-3p–DAT–IGF1R axis as a therapeutic strategy in a Parkinson’s disease model

Fig. 3

The high expression of miR-186-3p in PD cellular models promotes the activation of apoptotic pathways, leading to increased levels of dopaminergic neuron apoptosis. A KEGG analysis of the functions enriched by the target genes possibly regulated by miR-186-3p. B Detection of miR-186-3p transfection efficiency using FISH; Scale bar: 10 µm. C Statistical graph of fluorescence intensity. D RT-qPCR to detect miR-186-3p transfection efficiency. E WB analysis was used to detect the expression of TH protein in PD cell models after transfection with miR-186-3p. F TH protein expression statistical graph. G Detection of cell apoptosis levels using FCM assay in PD cell models after transfection with miR-186-3p. H Statistical graph of apoptosis levels. I Detection of cell viability using CCK8 assay. J WB analysis for the detection of P-PI3K, PI3K, P-AKT and AKT protein expression. K, L P-PI3K and P-AKT protein expression statistical graph. M WB analysis for the detection the expression of Cleaved caspase-3, Cytochrome c, Bax, and Bcl-2 protein. N, O Protein expression statistical graph. Data are presented as mean ± standard deviation. One-way ANOVA was used to compare differences among multiple groups. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. *P < 0.05 inhibitor group vs. NC group.. #P < 0.05 mimic group vs. NC group

Back to article page